Allworth Financial’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $145K | Buy |
2,644
+851
| +47% | +$46.8K | ﹤0.01% | 1327 |
|
|
2025
Q1 | $112K | Sell |
1,793
-111
| -6% | -$6.96K | ﹤0.01% | 1167 |
|
|
2024
Q4 | $118K | Buy |
1,904
+127
| +7% | +$7.88K | ﹤0.01% | 1180 |
|
|
2024
Q3 | $125K | Sell |
1,777
-191
| -10% | -$13.4K | ﹤0.01% | 983 |
|
|
2024
Q2 | $165K | Buy |
1,968
+4
| +0.2% | +$336 | ﹤0.01% | 880 |
|
|
2024
Q1 | $172K | Buy |
1,964
+1,360
| +225% | +$119K | ﹤0.01% | 828 |
|
|
2023
Q4 | $58.2K | Buy |
604
+214
| +55% | +$20.6K | ﹤0.01% | 1143 |
|
|
2023
Q3 | $34.5K | Buy |
390
+44
| +13% | +$3.89K | ﹤0.01% | 1260 |
|
|
2023
Q2 | $30K | Sell |
346
-10
| -3% | -$867 | ﹤0.01% | 1320 |
|
|
2023
Q1 | $34.6K | Buy |
356
+130
| +58% | +$12.6K | ﹤0.01% | 1213 |
|
|
2022
Q4 | $23.4K | Buy |
226
+27
| +14% | +$2.79K | ﹤0.01% | 1290 |
|
|
2022
Q3 | $17K | Buy |
199
+39
| +24% | +$3.33K | ﹤0.01% | 1358 |
|
|
2022
Q2 | $13K | Sell |
160
-102
| -39% | -$8.29K | ﹤0.01% | 1428 |
|
|
2022
Q1 | $20K | Hold |
262
| – | – | ﹤0.01% | 1255 |
|
|
2021
Q4 | $23K | Hold |
262
| – | – | ﹤0.01% | 1057 |
|
|
2021
Q3 | $20K | Buy |
262
+126
| +93% | +$9.62K | ﹤0.01% | 1023 |
|
|
2021
Q2 | $11K | Sell |
136
-25
| -16% | -$2.02K | ﹤0.01% | 1009 |
|
|
2021
Q1 | $12K | Buy |
161
+21
| +15% | +$1.57K | ﹤0.01% | 927 |
|
|
2020
Q4 | $12K | Hold |
140
| – | – | ﹤0.01% | 782 |
|
|
2020
Q3 | $11K | Buy |
140
+25
| +22% | +$1.96K | ﹤0.01% | 684 |
|
|
2020
Q2 | $14K | Hold |
115
| – | – | ﹤0.01% | 651 |
|
|
2020
Q1 | $10K | Hold |
115
| – | – | ﹤0.01% | 693 |
|
|
2019
Q4 | $10K | Buy |
+115
| New | +$10K | ﹤0.01% | 642 |
|